Skip to main content
Amiko M. Uchida
( out of 25 reviews )

Amiko M. Uchida, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Gastroenterology, Area E
801-213-9797
  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor June Round PhD and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    4.9 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 07, 2023
    UH HOSPITALS AND CLINICS

    I am beyond pleased with the experience and care from Dr. Uchida. She was friendly, listened, and answered all my questions. For the first time in 20 years, I feel like I'm being taken care of.

    August 01, 2023
    UH HOSPITALS AND CLINICS

    Dr. Uchida was very professional and personable, helping me feel at ease right away with her knowledge and bedside manner. I feel like she totally listened to and understood my concerns and did her very best to help me work through the issues I have been facing with my health. She stayed late and didn't make us feel like we were taking her valuable time. Thank you so much!

    July 14, 2023
    UH HOSPITALS AND CLINICS

    Dr Uchida is probably the very best GI Ive ever seen, and Ive seen plenty over my military career and into civilian life. She cares, shes attentive and most of all she is knowledgeable and makes decisions based on the most current medical studies and results. Shes the best.

    April 30, 2023
    UH HOSPITALS AND CLINICS

    She is outstanding

    April 08, 2023
    UH HOSPITALS AND CLINICS

    Dr Uchida is an amazing Dr. Very knowledgeable and caring. I've seen quite a few GI Doctors but she is the best.

    February 23, 2023
    UH HOSPITALS AND CLINICS

    Her entire staff makes me feel heard and comforted. She is also so kind and considerate, but also extremely knowledgeable and confident in her understanding of the disease.

    January 28, 2023
    UH HOSPITALS AND CLINICS

    Dr Uchida is so happy and positive. She is easy to talk to.

    January 21, 2023
    UH HOSPITALS AND CLINICS

    I would say that it has been as needed.

    January 19, 2023
    UH HOSPITALS AND CLINICS

    This was unlike any healthcare visit I have had before. Dr. Uchida was so friendly, attentive and took a lot of time to find out what was going on, what I was concerned about and to educate me on what I would need to know to be a part of my own treatment. She seemed to genuinely care about me as a person and spent so much time with me! She very knowledgeable and well researched about EOE. I am so glad that I have the opportunity to work with her!!

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor June Round PhD and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Fellowship Eosinophilic Esophagitis and Inflammatory Bowel Disease - Massachusetts General Hospital Advanced Fellow
    Gastroenterology - Massachusetts General Hospital Fellow
    Residency Internal Medicine - University of Washington Intern/Resident
    Medicine - University of Utah School of Medicine M.D.
    Undergraduate Major: Zoology; Minor: Chemistry - Weber State University B.S.

    Selected Publications

    Journal Article

    1. Uchida AM, Burk CM, Rothenberg ME, Furuta GT, Spergel JM (2023). Recent advances in the treatment of eosinophilic esophagitis. J Allergy Clin Immunol Pract. (Read full article)
    2. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ (2023). Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol. (Read full article)
    3. Warner ASC, Ufere NN, Patel NJ, Lau ES, Uchida AM, Hills-Dunlap K, Bromberg GK, Cunningham EA, Tagerman MD, Mills GG, Palamara K, Rigotti NA, Burnett-Bowie SM, Yeh DD, Tanguturi VK (2022). A Women in Medicine Trainees' Council: a model for women trainee professional development. Postgrad Med J, 99(1168), 79-82. (Read full article)
    4. Uchida AM, Ro G, Garber JJ, Roelstraete B, Ludvigsson JF (2022). Prior hospital-based infection and risk of eosinophilic esophagitis in a Swedish nationwide case-control study. United European Gastroenterol J, 10(9), 999-1007. (Read full article)
    5. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson KA (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. Am J Gastroenterol, 118(2), 263-268. (Read full article)
    6. Pyne AL, Hazel MW, Uchida AM, Qeadan F, Jordan KC, Holman A, Harward B, Gleich GJ, Peterson KA (2022). Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis. Aliment Pharmacol Ther, 56(9), 1328-1336. (Read full article)
    7. Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK (2022). Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Front Immunol, 13, 946643. (Read full article)
    8. Kummerlowe C, Mwakamui S, Hughes TK, Mulugeta N, Mudenda V, Besa E, Zyambo K, Shay JES, Fleming I, Vukovic M, Doran BA, Aicher TP, Wadsworth MH 2nd, Bramante JT, Uchida AM, Fardoos R, Asowata OE, Herbert N, Yilmaz H, Klverpris HN, Garber JJ, Ordovas-Montaes J, Gartner ZJ, Wallach T, Shalek AK, Kelly P (2022). Single-cell profiling of environmental enteropathy reveals signatures of epithelial remodeling and immune activation. Sci Transl Med, 14(660), eabi8633. (Read full article)
    9. Garber JJ, Roelstraete B, Lochhead PJ, Uchida AM, Michalsson K, Oln O, Ludvigsson JF (2022). Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study. Esophagus. (Read full article)
    10. Garber JJ, Lochhead PJ, Uchida AM, Roelstraete B, Bergman D, Clements MS, Ludvigsson JF (2022). Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study. Esophagus. (Read full article)
    11. Lenehan PJ, Cirella A, Uchida AM, Crowley SJ, Sharova T, Boland G, Dougan M, Dougan SK, Heckler M (2021). Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunother Adv, 1(1), ltab011. (Read full article)
    12. Przybyszewski EM, Deshpande V, Uchida AM (2020). An Unsuspected Cause of Rectal Bleeding. Gastroenterology, 160(4), e1-e2. (Read full article)
    13. Kumar NL, Kugener G, Vemula A, Wasan S, Uchida AM, Scheid FJ, Yarze J, Saltzman JR (2020). Multi-center prospective validation study of the SAFE-T colonoscopy evaluation tool: a web-based smartphone application for evaluation of gastroenterology fellow performance in colonoscopy. Gastroenterol Rep (Oxf).
    14. Uchida AM, Boden EK, James EA, Shows DM, Konecny AJ, Lord JD (2020). Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease. Cell Mol Gastroenterol Hepatol, 10(3), 507-526. (Read full article)
    15. Chou DB, Sworder B, Bouladoux N, Roy CN, Uchida AM, Grigg M, Robey PG, Belkaid Y (2012). Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection. J Leukoc Biol, 92(1), 123-31. (Read full article)
    16. Uchida AM, Meyers RA, Cooper BG, Goller F (2010). Fibre architecture and song activation rates of syringeal muscles are not lateralized in the European starling. J Exp Biol, 213(Pt 7), 1069-78. (Read full article)

    Review

    1. Uchida AM, Ro G, Garber JJ, Peterson KA, Round JL (2022). Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. [Review]. Front Immunol, 13, 943518. (Read full article)

    Editorial

    1. Uchida AM, Dougan M (2021). Editorial: Penetration of food protein through the oesophageal mucosa-is this where EoE starts? Aliment Pharmacol Ther, 53(3), 447-448. (Read full article)

    Letter

    1. Spechler SJ, Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF (2023). Reply. [Letter to the editor]. Clin Gastroenterol Hepatol. (Read full article)
    2. Uchida AM, Rabinowitz LG, Harris CE, Clark VR, Duma N, Willers H (2021). Baby Steps in the Right Direction: Toward a Parental Leave Policy for Gastroenterology Fellows. [Letter to the editor]. Am J Gastroenterol, 116(11), 2300. (Read full article)
    3. Uchida AM, Lenehan PJ, Vimalathas P, Miller KC, Valencia-Yang M, Qiang L, Canha LA, Ali LR, Dougan M, Garber JJ, Dougan SK (2021). Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis. [Letter to the editor]. Allergy, 77, 656-660. (Read full article)
    4. Harris CE, Clark VR, Duma N, Uchida AM, Kowalski A (2021). Re: "The Intersection of Disability and Pregnancy: Risks for Maternal Morbidity and Mortality" by Signore et al. [Letter to the editor]. J Womens Health (Larchmt), 30(9), 1362-1363. (Read full article)

    Abstract

    1. Uchida AM, Vimalalthas P, Valencia-Yang M, Miller K, Garber J (2020). The IL-33 receptor ST2 is highly induced on IL- 13-expressing tissue eosinophils in eosinophilic esophagitis [Abstract]. 145(2), 43.
  • News & Podcasts